A detailed history of Modus Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Modus Advisors, LLC holds 7,115 shares of AMGN stock, worth $2.29 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
7,115
Previous 6,660 6.83%
Holding current value
$2.29 Million
Previous $1.89 Million 17.43%
% of portfolio
0.81%
Previous 0.71%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$262.75 - $319.31 $119,551 - $145,286
455 Added 6.83%
7,115 $2.22 Million
Q1 2024

Apr 02, 2024

BUY
$268.87 - $324.56 $1.79 Million - $2.16 Million
6,660 New
6,660 $1.89 Million
Q3 2021

Oct 08, 2021

SELL
$212.27 - $248.7 $15,920 - $18,652
-75 Closed
0 $0
Q2 2021

Jul 01, 2021

BUY
$233.58 - $259.14 $17,518 - $19,435
75 New
75 $18,000
Q3 2020

Oct 01, 2020

SELL
$234.65 - $260.95 $17,598 - $19,571
-75 Closed
0 $0
Q2 2020

Jul 01, 2020

BUY
$197.81 - $242.74 $14,835 - $18,205
75 New
75 $18,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Modus Advisors, LLC Portfolio

Follow Modus Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Modus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modus Advisors, LLC with notifications on news.